KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

HCA Healthcare (HCA) EBITDA Margin (2016 - 2026)

HCA Healthcare (HCA) has disclosed EBITDA Margin for 17 consecutive years, with 2.96% as the latest value for Q1 2026.

  • For Q1 2026, EBITDA Margin rose 532.0% year-over-year to 2.96%; the TTM value through Mar 2026 reached 9.9%, down 101.0%, while the annual FY2025 figure was 7.37%, 17.0% up from the prior year.
  • EBITDA Margin hit 2.96% in Q1 2026 for HCA Healthcare, up from 24.72% in the prior quarter.
  • Across five years, EBITDA Margin topped out at 17.73% in Q4 2022 and bottomed at 25.84% in Q4 2024.
  • Average EBITDA Margin over 5 years is 1.1%, with a median of 8.46% recorded in 2022.
  • Year-over-year, EBITDA Margin crashed -3697bps in 2024 and then soared 532bps in 2026.
  • HCA Healthcare's EBITDA Margin stood at 17.73% in 2022, then crashed by -37bps to 11.14% in 2023, then tumbled by -332bps to 25.84% in 2024, then grew by 4bps to 24.72% in 2025, then surged by 88bps to 2.96% in 2026.
  • According to Business Quant data, EBITDA Margin over the past three periods came in at 2.96%, 24.72%, and 9.1% for Q1 2026, Q4 2025, and Q3 2025 respectively.